ClinConnect ClinConnect Logo
Search / Trial NCT03803891

Endoscopic Full-Thickness Resection In Colon

Launched by FUNDACIÓ INSTITUT GERMANS TRIAS I PUJOL · Jan 10, 2019

Trial Information

Current as of June 24, 2025

Unknown status

Keywords

Endoscopic Resection Colonoscopy Full Thickness Resection

ClinConnect Summary

Early detection and endoscopic resection of early neoplastic lesions in colon can prevent the development of colon cancer.

The classic endoscopic mucosal resection technique and the submucosal dissection technique require the creation of a submucosal "cushion" by injecting crystalloid substances or colloids. However, these advanced techniques have technical limitations when facing a lesion that presents poor lifting or non-lifting at all as it might be observed in scarring or fibrotic lesions

Endoscopic full-thickness resection (EFTR) in the colon using an over-the-scope clip (OTSC) is a ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (≥18 years) of both sexes.
  • Colonic lesions less than 30mm unresectable en-bloc by other less invasive endoscopic techniques, including lesions suggestive of T1, subepithelial tumors, lesions with diverticular involvement, lesions with no-lifting signs (recurrent, incomplete prior resection or untreated).
  • Patients who give their written informed consent for the procedure and for the study.
  • Exclusion Criteria:
  • Refusal to grant informed consent.
  • Neoplastic lesions of the colon with evidence of advanced stage (for example, lymph node involvement) or more than 3 cm in greatest diameter.
  • Any medical, psychological, geographical, or social problem that is significant and uncontrolled that may interfere with the patient's participation in the study or that does not allow adequate follow-up and adherence to the protocol and evaluation of the results of the study.

About Fundació Institut Germans Trias I Pujol

Fundació Institut Germans Trias i Pujol is a leading biomedical research institution based in Spain, dedicated to advancing health sciences through innovative clinical trials and translational research. With a strong commitment to improving patient outcomes, the foundation collaborates with academic, clinical, and industry partners to facilitate cutting-edge studies in various medical fields. Their multidisciplinary approach leverages state-of-the-art facilities and expertise to foster discoveries that translate into practical applications for healthcare, ultimately enhancing the quality of life for patients.

Locations

Madrid, , Spain

Madrid, , Spain

Madrid, , Spain

Barcelona, , Spain

Madrid, , Spain

Elche, Alicante, Spain

Pamplona, Navarra, Spain

Ciudad Real, , Spain

Terrassa, Barcelona, Spain

Oviedo, , Spain

Sant Joan Despí, Barcelona, Spain

Madrid, , Spain

Santiago De Compostela, La Coruña, Spain

Manresa, Barcelona, Spain

Castelló De La Plana, Castellón, Spain

Málaga, , Spain

Patients applied

0 patients applied

Trial Officials

Hugo I. Uchima Koecklin, MD

Principal Investigator

Medical researcher

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials